Tender detail
Supply of cytostatic medicines
Summary
The Marius Nasta Institute of Pneumophthisiology is procuring oncology medicines in 34 lots for supply to its pharmacy in Bucharest. The 24-month framework agreement has an estimated maximum value of RON 168,699,693.60 and may include up to three suppliers. The lots cover different medicines and formulations, including nivolumab, pembrolizumab, amivantamab, paclitaxel, docetaxel and bevacizumab.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.